Epitel, Inc. has secured $26 million in Series B funding, marking a significant follow-on round for the AI-driven brain health technology company. This capital infusion will fuel the expansion of their REMI® Remote EEG Monitoring System. The company did not disclose specific metrics like client numbers or revenue in this announcement.